Y-mAbs Therapeutics, Inc.
NASDAQ:YMAB
4.91 (USD) • At close March 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -29.666 | -21.427 | -95.568 | -55.275 | -119.337 | -81.028 | -43.274 | -19.161 | -17.057 |
| Depreciation & Amortization
| 0.535 | 0.735 | 0.839 | 0.782 | 0.396 | 0.166 | 0.029 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 1.897 | -0.576 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 14.559 | 14.453 | 25.603 | 19.334 | 16.137 | 4.657 | 1.966 | 0.609 | 0.258 |
| Change In Working Capital
| 0 | -19.734 | -10.371 | -7.284 | 3.444 | 2.665 | -0.047 | 2.745 | 3.353 |
| Accounts Receivables
| 2.246 | -9.923 | -4.819 | -7.712 | -7.376 | 0 | 0 | 0 | 0 |
| Inventory
| -2.149 | 1.637 | -1.19 | -5.512 | 7.376 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -1.385 | -6.856 | -0.919 | 4.18 | 0.852 | 2.617 | 1.261 | 2.385 | 0.836 |
| Other Working Capital
| 0 | -4.592 | -3.443 | 1.76 | 2.592 | 0.048 | -1.308 | 0.36 | 2.517 |
| Other Non Cash Items
| -1.142 | -1.259 | 3.577 | -62.01 | 8.707 | 0.043 | 0.097 | -0.063 | 2.28 |
| Operating Cash Flow
| -15.714 | -27.232 | -75.921 | -102.556 | -91.231 | -73.497 | -41.229 | -15.87 | -11.166 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | -0.967 | -0.175 | -1.965 | -0.234 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 62.01 | -2.61 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | 61.043 | -2.785 | -1.965 | -0.234 | 0 | 0 |
| Financing Activities: | |||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0.1 | 0.084 | 107.725 | 2.004 | 134.704 | 99.765 | 89.844 | 19.338 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.366 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 4.311 | 0.1 | 0.084 | 0.589 | 2.004 | 0 | -1.002 | -0.258 | 0 |
| Financing Cash Flow
| 4.311 | 0.1 | 0.084 | 108.314 | 2.004 | 134.704 | 98.763 | 89.586 | 18.972 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0 | 0.007 | 0.035 | 0.129 | -0.49 | 0.023 | 0.056 | -0.108 | 0 |
| Net Change In Cash
| -11.403 | -27.125 | -75.802 | 66.93 | -92.502 | 59.265 | 57.356 | 73.608 | 7.806 |
| Cash At End Of Period
| 67.234 | 78.637 | 105.762 | 181.564 | 114.634 | 207.136 | 147.871 | 90.483 | 16.875 |